Baker McKenzie Baker McKenzie
How Can We Help?
  • Home
  • Expertise
  • 医疗与生命科学
Language:
中文(简体)

医疗与生命科学

Purple loop
Insight | 宣传册

Data PULSE

Our Data PULSE platform helps you navigate the complex landscape of data, regulatory and IP protection concerns at each stage of the medical product life cycle.
Read More

Healthcare and life sciences companies face immense opportunity and disruption. The increasing innovation in new product breakthroughs; interplay between drugs, devices and tech; cost pressures; and demand for patient centricity have created a melting pot for agility and change.

Businesses turn to Baker McKenzie to enter new markets, maximize operational efficiencies, build a long-term pipeline of innovative products and demonstrate efficacy. We provide commercial legal advice to help anticipate and manage new risk and avoid disconnect between global strategy and the law enabling your company to provide better care to patients across the globe.

Visit InsightPlus for our latest legal updates covering Healthcare & Life Sciences developments across the globe

Insight | 宣传册
Unlocking and Accelerating Growth: Healthcare and Life Sciences in Asia Pacific
Healthcare and life sciences breakthroughs offer opportunities to meet patient needs and create value, but rising costs and market uncertainty also apply significant pressure to operations.
Insight | 书籍
Ukrainian Laws in Wartime
Our guide provides an overview of the key features of wartime legislation.
Insight | 客户/法律动态
WHO Releases AI Ethics and Governance Guidance for Large Multimodal Models
The WHO guidance summarizes the broad applications of LMMs in the healthcare industry, including recommendations for governments, and for public health and medical purposes.
Insight | 宣传册
The Year Ahead: Global Disputes Forecast 2024 Report
Our seventh annual report provides detailed analysis of disputes trends to prepare your organization for 2024.
Insight | 客户/法律动态
Supporting clients to seize Korea’s substantial opportunities
Our lawyers discuss the abundant opportunities that Korea presents and how the JV supports clients with their Korea inbound and outbound investments and business expansion. 
Insight | 书籍
Guide to IPOs for Biotech and Pharma Companies
Biotech and pharma companies undertaking capital raisings can approach the world’s capital markets in various ways.
Insight | 客户/法律动态
How Has 2023 Panned Out for the Life Sciences Industry in Asia Pacific?
Ben McLaughlin and Andrew Martin discuss key trends and developments in 2023.
Insight | Podcast
Talking M&A
From navigating the complexities of carve-outs or tech transactions to cross-border trends, gain expert insights and uncover key topics in a complex transactional landscape.
Insight | Podcast
The Health Pod
The Health Pod, Baker McKenzie's industry podcast series, highlights sector-specific issues and trends that affect healthcare and life sciences companies.
Insight | 书籍
Doing Business in Peru 2023
The topics covered in this guide range from the promotion of private investment and tax regimes, to the general framework of the most important sectors in Peru.
Insight | 书籍
Doing Business in the United Arab Emirates 2023
Comprehensive guide to understanding the current investment and legal landscape in the UAE.
View All Insight
News | 交易公告
Baker McKenzie advises Sino Biopharmaceutical on its partnership with Boehringer Ingelheim to bring innovative cancer therapies to China
The two companies will develop and commercialize a number of Boehringer's innovative oncology products.
News | 交易公告
Baker McKenzie advises Idorsia and Viatris on entering into significant global research and development collaboration agreements
Under the agreements Viatris will receive exclusive worldwide development and commercialization rights for two Phase 3 assets.
News | 本所新闻
Healthcare and Life Sciences in Asia Pacific: 2024 sets to see rising investment and innovation
According to Baker McKenzie's new digital report “Unlocking and Accelerating Growth: Healthcare and Life Sciences in Asia Pacific.” 
News | 本所新闻
2024 Legal 500 EMEA Guide Highlights Growth in Baker McKenzie Lawyer Rankings
The guide ranks Baker McKenzie in 277 practice areas and its lawyers in 292 categories.
News | 奖项
Baker McKenzie Partners Leif King and Randy Sunberg Recognized Among Legal 500's 2024 M&A Powerlist
List showcases the leading mergers and acquisitions practitioners who are 'deemed the gold standard' working across the region.
News | 交易公告
Baker McKenzie Client Takeda Enters Worldwide License and Collaboration Agreement for Rusfertide
Rusfertide is currently in trial, VERIFY, for the treatment of Polycythemia Vera, a rare chronic blood disorder. 
News | 本所新闻
Chambers Asia Pacific 2024 ranks Baker McKenzie in 151 practices
Chambers Asia Pacific has released its 2024 guide, ranking Baker McKenzie and its member firms collectively in 151 practice areas and in 234 lawyer categories, of which 91 practice areas and 92 ...
News | 交易公告
Baker McKenzie assists Government of Victoria to deliver a new state-of-the-art manufacturing facility for mRNA therapies at La Trobe University
The facility will produce next generation mRNA vaccines and treatments for clinical trials as well as research-grade RNA materials.
News | 交易公告
Baker McKenzie advises SPIMACO in acquisition of 68.0% of shares of Osmopharm
Baker McKenzie advised SPIMACO on the acquisition of 68.0% of the shares in Swiss pharmaceutical company Osmopharm
News | 本所新闻
Baker McKenzie Announces Global Revenues of USD $3.3 Billion
Our revenues of USD $3.3 billion for the fiscal year ended 30 June 2023 are up 2.5% on a currency neutral basis.  
News | 交易公告
Baker McKenzie Client Sanofi Completes Sale of Latin America Generics Business - Genfar
Baker McKenzie advised global pharmaceuticals company Sanofi in the sale of its generics business in Colombia, Ecuador and Peru.
浏览全部新闻

Ranked in the Top 4 Law Firms in the World for Life Sciences, Chambers Global

Americas

  • Ranked in Healthcare: Pharmaceutical/Medical Products Regulatory, Chambers USA 2022 (District of Columbia)
  • Impact Deal of the Year - Poseida Therapeutics/Takeda, LMG Life Sciences Americas 2022 (US)
  • Impact Deal of the Year - Pfizer/Trillium Therapeutics, LMG Life Sciences Americas 2022 (Canada)
  • FDA Regulatory Firm to Watch, LMG Life Sciences Awards 2021 and 2020 (US)
  • Licensing and Collaborations Recommended Firm, LMG Life Sciences 2021 and 2020 (US)
  • Financial & Corporate Firm to Watch, LMG Life Sciences Awards 2019 (US)
  • Band 1 for Life Sciences, Chambers Latin America 2023 (Mexico)
  • Band 2 for Life Sciences and Healthcare, Chambers Latin America 2023 (Peru)
  • Tier 1 for Life Sciences and Healthcare, Legal 500 Latin America 2023 (Argentina)
  • Tier 1 for Life Sciences, Legal 500 Latin America 2023 (Mexico)
  • Tier 2 for Life Sciences, Legal 500 Latin America 2023 (Colombia)

Europe, Middle East and Africa

  • Regulatory Firm of the Year, LMG Life Sciences EMEA 2022 (Türkiye) - Esin Attorney Partnership (a Member Firm of Baker McKenzie International)
  • Türkiye Firm of the Year, LMG Life Sciences EMEA 2022 (Türkiye) - Esin Attorney Partnership (a Member Firm of Baker McKenzie International)
  • Impact Deal - Vifor Pharma / Sanifit, LMG Life Sciences EMEA 2022 (Türkiye) - Esin Attorney Partnership (a Member Firm of Baker McKenzie International)
  • Band 1 for Life Sciences, Chambers Europe 2023 (Hungary)
  • Band 2 for Life Sciences, Chambers Europe 2023 (Germany and Spain)
  • Tier 1 for Healthcare & Life Sciences (Industry Focus and Regulatory), Legal 500 EMEA 2022 (Germany)
  • Tier 2 for Healthcare & Life Sciences (Industry Focus), Legal 500 EMEA 2022 (France, Italy, Spain)
  • Tier 2 for Healthcare & Life Sciences (Industry Focus), Legal 500 UK 2023 (London)
  • Law Firm of the Year for Health and Research, Top Legal Industry Awards (Italy)

Asia Pacific

  • Band 1 for Life Sciences, Chambers Global 2014 to 2023 and Chambers Asia Pacific 2014 to 2023
  • Medical and Healthcare Law Firm of the Year, Asian Legal Business Southeast Asia Law Awards 2017 to 2021
  • Band 2 for Life Sciences, Chambers Asia Pacific 2023 (Australia)
  • Band 2 for Life Sciences (International Firms), Chambers Greater China Region 2023 (China)
  • Tier 1 for Healthcare and Life Sciences (Foreign Firms), Legal 500 Asia Pacific 2023 (China)

Explore Healthcare & Life Sciences

Healthcare & Life Sciences Hub

Healthcare & Life Sciences Hub

Stay apprised on key market trends, risks, opportunities and legal issues through our dedicated resources hub.

Healthtech and Biotech M&A

The healthcare tech and biotech industries shifted fundamentally during the pandemic. Enthusiasm for dealmaking continues to be a growth area.

>> 16-minute listen

FT Big Deal Series: The Healthtech Sector’s Spectacular Surge in SPACs and de-SPACS

A three minute video discussing how the pandemic triggered a significant rise in SPAC investments in the healthtech sector.


healthcare icons on blue backgrounc

Healthcare & Life Sciences Supply Chain Webinar Series 

Focuses on the trends, issues and opportunities along each stage of supply chain life cycle for healthcare and life sciences companies.

Flares of different colored light against a black background

Guide to IPOs for Biotech and Pharma Companies

Biotech and pharma companies undertaking capital raisings can approach the world’s capital markets in various ways.


Global Healthcare & Life Sciences Webinar Series

Aims to share legal industry insights and provide practical guidance in the context of today's evolving world.

About Us

Learn about our Global Healthcare & Life Sciences Industry Group in 5 minutes

Hyper-Hybridity

Explores trends and opportunities in digital health from the perspective of three key players in the ecosystem: healthcare and life sciences organizations, technology companies and investors
Banner for Promoting Medical Products Handbook

Promoting Medical Products Globally

Understand legal developments and regulations related to ethical business interactions between medical companies and healthcare professionals in 35 countries

How We Can Help

Key Contacts